This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Infective endocarditis (acute)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Acute infective endocarditis is a rare disease found in IV drug abusers or the immunosuppressed, or following an acute suppurative illness such as pneumonia or meningitis. Normal valves are affected in 50% of cases.

Most cases are due to Staph. aureus but Strep. pneumoniae, Haemophilus influenzae, gonococcus and meningococcus may be involved.

The condition has a stormy onset with a persistent fever, chills, weakness and lassitude. The onset of endocarditis is suggested by the development of heart murmurs, vasculitis and emboli, including metastatic abscesses.

The development of severe heart failure may indicate chordal rupture or acute valvular destruction.

Acute infective endocarditis is distinguished from the more common subacute form of endocarditis on the basis of the virulence of the pathogenic organism involved and clinical presentation. The incidence, investigation, treatment etc. of acute infective endocarditis is considered together with the other forms of endocarditis.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.